Here's why these two healthcare stocks scan as no-brainer buys right now.

Sana Biotechnology Inc. (NASDAQ: SANA) is a must-buy penny stock according to analysts. On November 7, Bank of America ...

Biotech investing can feel a little bit like a Vegas sportsbook sometimes. Pick the company with the right drug trial and you ...

The best healthcare stocks from Goldman Sachs' list that are also Quant Strong Buys have attractive valuations and forward ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has not performed well for most of the year, and the company's latest quarterly update ...

This biotech has already made impressive contributions to medicine, and it could make more. But does that make it a buy?

Krystal Biotech drives Vyjuvek growth, premium margins, global expansion, a $1B goal, and pipeline data ahead with a $219.50 ...

The market just handed patient investors a gift -- three high-growth companies solving real problems, now trading at 30-day ...

Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL) dominates the search engine market with a greater than 90% share, powering billions of ...

They’re called in-kind contributions, and they now account for a growing share of digital-asset treasury, or DAT, deals.

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best small-cap biotech stocks to buy according to analysts.

Merck agreed to pay $9.2 billion to purchase Cidara Therapeutics, looking to cash in on the firm's experimental flu treatment.